CUTISS announces positive Phase 2 clinical trial results for denovoSkin™
CUTISS announces results from Phase 2 clinical trials for denovoSkin™ in adolescent and adult burn patients, and Phase 1 in children Phase 2 clinical trial reaches efficacy endpoint with high statistical significance for lead product denovoSkin™ in adult and adolescent burn patients. Phase 1 clinical trial of denovoSkin™ is completed with 5-year follow up demonstrating …
CUTISS announces positive Phase 2 clinical trial results for denovoSkin™ Read More »
